+
Site Tour

Search

  • Transcatheter Replacement

    The concept of TAVI involves the use of a stent-mounted bioprosthetic valve which is deployed in the aortic position using vascular catheterisation techniques. This approach avoids sternotomy and…
  • Guidelines

    Asymptomatic patients Intervention is recommended in asymptomatic patients with severe aortic stenosis and systolic LV dysfunction (LVEF <50%) without another cause (class I, B). …
  • Clinical Data

    EXCELLENT OUTCOMES IN CLINICAL TRIAL RESULTS 30-DAY1,2 1 YEAR1,2 FIND OUT MORE: Clinical trials  CLINICAL INSIGHTS 30-DAY 30-DAY NAVITOR™1,2 N=120 EVOLUT‡…
  • Medical Management

    Traditional medical management of MR (both PMR and SMR) may, to an extent, relieve the symptoms of the condition, but is often insufficient at controlling the severity and progression of MR.21 ©…
  • Transcatheter Repair

    Transcatheter edge-to-edge repair (TEER) is a minimally invasive option: Overall, many patients in need of valve reconstruction or replacement do not undergo surgery because of high perioperative…
  • Transcatheter Replacement

    TRANSCATHETER Mitral Valve Replacement (TMVr): To date, TMVR has generally been used in: Surgical high-risk patients. Patients who are not candidates for TMVr as their mitral valve anatomy is…
  • Diagnosis

    Characteristics that are strongly associated with a causal role of PFO in an ischemic stroke of unknown cause are:9 Atrial septal aneurysm (ASA) and/or a moderate-to-severe shunt Atrial septal…
  • Guidelines & Recommendations

    Compelling data resulted in positive guidelines recommending PFO closure Long-term data from the both the RESPECT trial12 and REDUCE trial,13 as well as data from the CLOSE trial,14 have revealed…
  • Diagnosis

    MR is a progressive disease, and patients may remain asymptomatic even when the condition has become severe, as compensatory mechanisms develop.11 In some cases, the following symptoms may be…
  • Launch Video

    WELCOME TO MY-CONNEXT.COM © Abbott 2024. All rights reserved. 9-EH-5-14953-01 02-2024

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline